Loading clinical trials...
Loading clinical trials...
The STandard Versus ImAging SuBstrate Aided Ablation in Severe Left VEntricular
Conditions
Interventions
Incorporation of CT and/or c-MRI derived myocardial scar with 3D electroanatomical mapping (EAM).
Locations
1
United States
Hospital of The University Of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
October 1, 2023
Primary Completion Date
March 1, 2024
Completion Date
March 1, 2024
Last Updated
May 20, 2025
NCT07547098
NCT07491315
NCT07487363
NCT07256249
NCT06909773
NCT06505109
Lead Sponsor
University of Pennsylvania
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions